Most Popular
- BMI Calculator
- TheFamilyGP TV
- Fertility Calculator
- Lose weight
- Online diets
- Dr Chris in the news
- Medicine Guide
Women's Health
Men's Health
Children's Health
BBC Health News
- Detention units 'fail on health'
- Hospital bug fine plan 'unfair'
- Asbestos pay-out ruling due
- Over-the-counter Viagra bid ends
- Heavy drinkers 'lie to doctors'
- NHS 'struggling' with work laws
- Key NHS reform 'delivered little'
- Rapid care 'cuts baby's HIV risk'
- Hospital to bury unclaimed organs
- About face! How babies in their buggies benefit from eye contact.
- Hidden dangers
- No belly button
- Walking tall
- Hearing aids
- Medical notes
- From BBC Health
- Windpipe transplant breakthrough
- Deal reached on NHS drug prices
- Nurses warn over needle injuries
- Lung disease diagnosis confusion
- Technology to eradicate malaria
- C.diff 'a factor in more deaths'
- Baby P doctor 'deeply affected'
- Anthrax found on teacher's drums
- Drug-resistant ward bug concern
- Pupils targeted in superbug fight
- Computer virus affects hospitals
- Heart disease and stroke
- Cancer: The facts
- Pregnancy timeline
The first vaccine that can prevent cervical cancer has been granted a licence
The first vaccine that can prevent cervical cancer and other human papillomavirus diseases has today (27th September 2006) been granted a licence by the European Commission. The licence has been granted for vaccination of children and adolescents 9 to15 years, and adult females 16 to 26 years of age.The following information is from the offical press release:
Professor Margaret Stanley, of the University of Cambridge, commented: "It is excellent news that Gardasil can now be used in the UK. In time, the introduction of human papillomavirus vaccination should not only mean that fewer women will die from cancer, but there should be fewer abnormal smear test results, fewer surgical interventions and less psychological distress for women in the UK."
Dr George Kassianos, GP and Immunisation spokesperson for the Royal College of General Practitioners, commented: "The development of a vaccine to provide protection against cervical cancer is a landmark achievement. The fact that it has taken just 10 months for this vaccine to gain approval is testament to the strength of the clinical trial data and the vaccine’s significance for women’s health. Everyone involved in the prevention and management of cervical cancer, genital warts and the other human papillomavirus diseases, will now be looking forward to the findings of the Joint Committee on Vaccination and Immunisation (JCVI) regarding the policy for vaccination in the UK."
Pamela Morton, Director of cervical cancer charity, Jo’s Trust, commented: "The licensing of the first human papillomavirus vaccine in the UK is the most significant development since the introduction of screening in the fight against cervical cancer. If available and used widely, this vaccine could not only allow us to provide unprecedented protection to future generations of women against this terrible disease but could also enable us to protect women of this generation who may have already been exposed to the virus."
Further information
More information can be found on these web sites:
www.jotrust.co.uk – the cervical cancer charity
www.cancerbackup.org.uk/Cancertype/Cervix
Cancer Research UK
Other resources
White paper on link between cervical cancer and HPV
NHS pocket guide to cervical smears (2004)
This content was created on Wed 27 September 2006
More like this
Women's Health
Illnesses
News and Comment
Prevention
Latest Blog Topics
Are breast self examinations a waste of time?Study suggests that breast self examinations do more harm than good. Is this true?
Happy 60th Birthday to the NHS
Dr Chris celebrates the achievements of the NHS
My Visit to Buckingham Palace
Dr. Chris meets the Queen and receives his MBE
